Search results
There are 375 drugs known to interact with Eliquis (apixaban), along with 4 disease interactions. Of the total drug interactions, 123 are major, 244 are moderate, and 8 are minor.
Some products that may interact with this drug include: mifepristone, other drugs that can cause bleeding/bruising (including antiplatelet drugs such as clopidogrel, NSAIDs such as ibuprofen ...
Jul 20, 2022 · Eliquis is a prescription drug used to treat or help prevent certain kinds of blood clots. Discover drug interactions in depth, when to avoid Eliquis, and more.
Oct 9, 2023 · Eliquis (apixaban) is used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Includes Eliquis side effects, interactions and indications.
Apixaban Interactions. There are 375 drugs known to interact with apixaban, along with 4 disease interactions. Of the total drug interactions, 123 are major, 244 are moderate, and 8 are minor.
May 25, 2023 · Drug interactions with Eliquis could make blood clots more likely or increase your risk of a serious bleeding event. Nonsteroidal anti-inflammatory drugs (NSAIDs), other blood thinners, and Paxlovid can interact with Eliquis.
Jun 18, 2022 · Eliquis has interactions with some other drugs and certain supplements. Examples include nonsteroidal anti-inflammatory drugs (NSAIDs), certain antidepressants, and grapefruit.
Mar 7, 2022 · What Drugs, Substances, or Supplements Interact with Eliquis? CYP3A4 inhibitors such as Serzone, Sporanox, Nizoral, Vfend, Reyataz, Biaxan and Ketek should not be taken while a patient is taking Eliquis.
Apixaban (Oral Route) Print. Before Using. Drug information provided by: Merative, Micromedex ®. In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: Allergies.
Sep 2, 2020 · These data suggest that apixaban has significant potential for drug‐drug interactions, either with CYP3A/P‐gp modulators or with drugs that may impair hemostasis. The most described adverse drug reactions were adverse drug reactions related to hemorrhage or thrombosis, mostly through pharmacodynamic interactions.
